Pharmacoeconomics of the management of acute exacerbations of chronic obstructive pulmonary disease

Bibliography

• GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Pulmonary Disease workshop summary. MCR VISION, Inc. (2006).
   Google Scholar
• ANTHONISEN NR, MANFREDA J, WARREN CP, HERSHFIELD ES, HARDING GK, NELSON NA: Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann. Intern. Med. (1987) 106:196-204.
   PubMed Web of Science ®Google Scholar
• SETHI S: Infectious etiology of acute exacerbations of chronic bronchitis. Chest (2000) 117(Suppl.):380-385.
   PubMedGoogle Scholar
• SEEMUNGAL TAR, DONALDSON GC, PAUL EA, BESTALL JC, JEFFRIES DJ, WEDZICHA JA: Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. (1998) 157:1418-1422.
   PubMed Web of Science ®Google Scholar
• SOTO FJ, VARKEY B: Evidence-based approach to acute exacerbations of COPD. Curr. Opin. Pulm. Med. (2003) 9:117-124.
   PubMed Web of Science ®Google Scholar
• LINDENAUER PK, PEKOW P, GAO S, CRAWFORD AS, GUTIERREZ B, BENJAMIN EM: Quality of care for patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. Ann. Intern. Med. (2006) 144:894-903.
   PubMed Web of Science ®Google Scholar
• CONNORS AF, DAWSON NV, THOMAS C et al.: Outcomes following acute exacerbation of severe chronic obstructive lung disease. Am. J. Respir. Crit. Care Med. (1996) 154:959-967.
   PubMed Web of Science ®Google Scholar
• SULLIVAN SD, RAMSEY SD, LEE TA: The economic burden of COPD. Chest (2000) 117(Suppl.):5-9.
   PubMed Web of Science ®Google Scholar
• CELLI BR, MACNEE W, ATS/ERS TASK FORCE: Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur. Respir. J. (2004) 23:932-946.
   PubMed Web of Science ®Google Scholar
• ALBERT RK, MARTIN TR, LEWIS SW: Controlled clinical trial of methylprednisolone in patients with chronic bronchitis and acute respiratory insufficiency. Ann. Intern. Med. (1980) 92:753-758.
   PubMed Web of Science ®Google Scholar
• THOMPSON WH, NIELSON CP, CARVALHO P, CHARAN NB, CROWLEY JJ: Controlled trial of oral prednisone in out-patients with acute COPD exacerbation. Am. J. Respir. Crit. Care Med. (1996) 152:407-412.
   Google Scholar
• DAVIES L, ANGUS RM, CALVERLEY PM: Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial. Lancet (1999) 354:456-460.
   PubMed Web of Science ®Google Scholar
• NIEWOEHNER DE, ERBLAND ML, DEUPREE RH et al.: Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. N. Engl. J. Med. (1999) 340:1941-1947.
   PubMed Web of Science ®Google Scholar
• INTERNATIONAL CONSENSUS CONFERENCES IN INTENSIVE CARE MEDICINE: Non-invasive positive pressure ventilation in acute respiratory failure. Am. J. Respir. Crit. Care Med. (2001) 163:283-291.
   PubMedGoogle Scholar
• MIRAVITLLES M, ZALACAIN R, MURIO C et al.: Speed of recovery from acute exacerbations of chronic obstructive pulmonary disease after treatment with antimicrobials. Results of a two-year study. Clin. Drug Invest. (2003) 23:439-450.
   PubMed Web of Science ®Google Scholar
• MIRAVITLLES M, LLOR C, NABERAN K, COTS JM, MOLINA J: Effect of various antimicrobial regimens on the clinical course of exacerbations of chronic bronchitis and chronic obstructive pulmonary disease in primary care. Clin. Drug Invest. (2004) 24:63-72.
   Web of Science ®Google Scholar
• WILSON R, ALLEGRA L, HUCHON G et al.: Short and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis. Chest (2004) 125:953-964.
   PubMed Web of Science ®Google Scholar
• WILSON R, SCHENTAG JJ, BALL P et al.: A comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and long-term clinical outcomes. Clin. Ther. (2002) 24:639-652.
   PubMed Web of Science ®Google Scholar
• BALTER MS, LA FORGE J, LOW DE, MANDELL L, GROSSMAN RF: Canadian guidelines for the management of acute exacerbations of chronic bronchitis. Can. Respir. J. (2003) 10(Suppl B):3-32.
   PubMedGoogle Scholar
• FALING LJ: Pulmonary rehabilitation-physical modalities. Clin. Chest Med. (1986) 7:599-618.
   PubMed Web of Science ®Google Scholar
• NEWTON DA, BEVANS HG: Physiotherapy and intermittent positive-pressure ventilation of chronic bronchitis. Br. Med. J. (1978) 2:1525-1528.
   PubMedGoogle Scholar
• SKWARSKA E, COHEN G, SKWARSKI KM et al.: Randomised controlled trial of supported discharge in patients with exacerbations of chronic obstructive pulmonary disease. Thorax (2000) 55:907-912.
   PubMed Web of Science ®Google Scholar
• CASAS A, TROOSTERS T, GARCIA-AYMERICH J et al.: Integrated care prevents hospitalizations for exacerbations in COPD patients. Eur. Respir. J. (2006) 28:123-130.
   PubMed Web of Science ®Google Scholar
• COTTON MM, BUCKNALL CE, DAGG KD et al.: Early discharge for patients with exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. Thorax (2000) 55:902-906.
   PubMed Web of Science ®Google Scholar
• RODRIGUEZ-ROISIN R: COPD exacerbations – 5: management. Thorax (2006) 61:535-544.
   PubMedGoogle Scholar
• CURRIE GP, WEDZICHA JA: ABC of chronic obstructive pulmonary disease: acute exacerbations. Br. Med. J. (2006) 333:87-89.
   PubMedGoogle Scholar
• MIRAVITTLES M, MURIO C, GUERRERO T, GISBERT R: Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD. Chest (2002) 121:1449-1455.
   PubMedGoogle Scholar
• RYCHLIK R, PFEIL T, DANIEL D et al.: Zur sozioökonomischen relevanz akuter exazerbationen der chronischen bronchitis in der Bundesrepublik Deutschland (Socioeconomic relevance of acute exacerbations of chronic bronchitis in the Federal Republic of Germany). Dtsch. Med. Wschr. (2001) 126:353-359.
   PubMedGoogle Scholar
• ANDERSSON F, BORG S, JANSSON SA et al.: The costs of exacerbations in chronic obstructive pulmonary disease (COPD). Respir. Med. (2002) 96:700-708.
   PubMed Web of Science ®Google Scholar
• OOSTENBRINK JB, RUTTEN-VAN MÖLKEN MPMH: Resource use and risk factors in high-cost exacerbations of COPD. Respir. Med. (2004) 98:883-891.
   PubMed Web of Science ®Google Scholar
• SCULPHER MJ, PANG FS, MANCA A et al.: Generalisability in economic evaluation studies in healthcare: a review and case studies. Health Techn. Assess. (2004) 8:1-206.
   Web of Science ®Google Scholar
• MIRAVITTLES M: Health status and costs of exacerbations of chronic bronchitis and COPD: how to improve antibiotic treatment. Expert Rev. Pharmacoeconomics Outcomes Res. (2005) 5:423-435.
   PubMedGoogle Scholar
• MIRAVITTLES M, JARDIM JR, ZITTO T, RODRIGUES JE, LOPEZ H: Pharmacoeconomic study of antibiotic therapy for acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease in Latin America. Arch. Bronconeumol. (2003) 39:549-553.
   PubMedGoogle Scholar
• NIEDERMAN MS, MCCOMBS JS, UNGER AN, KUMAR A, POPOVIAN R: Treatment cost of acute exacerbations of chronic bronchits. Clin. Ther. (1999) 21:576-591.
   PubMed Web of Science ®Google Scholar
• LUCIONI C, DONNER CF, DE BENEDETTO F et al.: I costi della broncopneumopatia cronica ostruttiva: la fase prospettica dello studio ICE (Italian costs for exacerbations in COPD). Pharmacoeconomics – Italian Research Articles (2005) 7:119-134.
   Google Scholar
• MCGUIRE A, IRWIN DE, FENN P et al.: The excess cost of acute exacerbations of chronic bronchitis in patients aged 45 and older in England and Wales. Value Health (2001) 4:370-375.
   PubMedGoogle Scholar
• DRUMMOND M, SCULPHER MJ, TORRANCE GW, O’BRIEN BJ, STODDART GL: Methods for the economic evaluation of health care programmes, 3rd rev. edn. Oxford University Press, Oxford (2005).
   Google Scholar
• BACKHOUSE R, SHAKESPEARE A, HUTTON J: Economic evaluation of alternative antibiotic regimens in the management of acute exacerbations of chronic bronchitis. Br. J. Med. Econ. (1995) 8:11-25.
   Google Scholar
• WOOL C, CERUTTI R, GARBAGNA N, GROSSI E: A cost-effectiveness study of four different antibiotics in the treatment of acute exacerbations of chronic obstructive pulmonary disease. Br. J. Med. Econ. (1996) 10:159-168.
   Google Scholar
• VAN BARLINGEN HJJ, NUIJTEN MJC, VOLMER T, SANDERSON DJ, LACEY LF: Model to evaluate the cost-effectiveness of different antibiotics in the management of acute bacterial exacerbations of chronic bronchitis in Germany. J. Drug Assess. (1998) 1:575-728.
   Google Scholar
• DESTACHE CJ, DEWAN N, O’DONOHUE WJ, CAMPBELL JC, ANGELILLO VA: Clinical and economic considerations in the treatment of acute exacerbations of chronic bronchitis. J. Antimicrob. Chemother. (1999) 43(Suppl. A):107-113.
   PubMed Web of Science ®Google Scholar
• PENG CC, ASPINALL SL, GOOD CB, ATWOOD CW, CHANG CCH: Equal effectiveness of older traditional antibiotics and newer broad-spectrum antibiotics in treating patients with acute exacerbations of chronic bronchitis. South. Med. J. (2003) 96:986-991.
   PubMedGoogle Scholar
• HALPERN MT, PALMER CS, ZODET M, KIRSCH J: Cost-effectiveness of gemifloxacin: results from the GLOBE study. Am. J. Health-Syst. Pharm. (2002) 59:1357-1365.
   PubMed Web of Science ®Google Scholar
• LLOR C, NABERAN K, COTS JM, MOLINA J, MIRAVITLLES M: Economic evaluation of the antibiotic treatment of exacerbations of chronic bronchitis and COPD in primary care. Int. J. Clin. Pract. (2004) 58:937-944.
   PubMed Web of Science ®Google Scholar
• GROSSMAN R, MUKHERJEE J, VAUGHAN D et al.: A 1-year community-based health economic study of ciprofloxacin vs usual antibiotic treatment in acute exacerbations of chronic bronchitis. Chest (1998) 113:131-141.
   PubMed Web of Science ®Google Scholar
• TORRANCE G, WALKER V, GROSSMAN R et al.: Economic evaluation of ciprofloxacin compared with usual antibacterial care for the treatment of acute exacerbations of chronic bronchitis in patients followed for 1 year. Pharmacoeconomics (1999) 16:499-520.
   PubMed Web of Science ®Google Scholar
• KEENAN SP, GREGOR J, SIBBALD WJ, COOK D, GAFNI A: Noninvasive positive pressure ventilation in the setting of severe, acute exacerbations of chronic obstructive pulmonary disease: more effective and less expensive. Crit. Care Med. (2000) 28:2094-2102.
   PubMedGoogle Scholar
• PLANT PK, OWEN JL, PARROTT S, ELLIOTT MW: Cost effectiveness of ward based non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease: economic analysis of randomised controlled trial. Br. Med. J. (2003) 326:956.
   PubMed Web of Science ®Google Scholar
• TUGGEY JM, PLANT PK, ELLIOTT MW: Domiciliary non-invasive ventilation for recurrent acidotic exacerbations of COPD: an economic analysis. Thorax (2003) 58:867-871.
   PubMed Web of Science ®Google Scholar
• HERNANDEZ C, CASAS A, ESCARRABILL J: Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients. Eur. Respir. J. (2003) 21:58-67.
   PubMed Web of Science ®Google Scholar
• BRITISH THORACIC SOCIETY: BTS guidelines for the management of chronic obstructive pulmonary disease. Thorax (1997) 52(Suppl 5):S1-S28.
   PubMed Web of Science ®Google Scholar
• SPIRITUS E: Antibiotic usage for respiratory tract infections in an era of rising resistance and increased cost pressure. Am. J. Manag. Care (2000) 23(Suppl 1):1216-1221.
   Google Scholar
• BALL P, TILLOTSON G, WILSON R: Chemotherapy for chronic bronchitis: controversies. Presse Med. (1995) 24:189-194.
   PubMedGoogle Scholar
• GAILLAT J: Objectives for antibiotic therapy in acute exacerbations of chronic bronchitis. Presse Med. (2001) 30:17-22.
   PubMedGoogle Scholar
• FELMINGHAM D: Comparative antimicrobial susceptibility of respiratory tract pathogens. Chemotherapy (2004) 50(Suppl 1):3-10.
   PubMed Web of Science ®Google Scholar
• FERRARA AM: New fluoroquinolones in lower respiratory tract infections and emerging patterns of pneumococcal resistance. Infection (2005) 33:106-114.
   PubMed Web of Science ®Google Scholar
• MARTINEZ FJ, ANZUETO A: Appropriate outpatient treatment of acute bacterial exacerbations of chronic bronchitis. Am. J. Med. (2005) 118(Suppl. 7A):39-44.
   Google Scholar
• KARDAS P: Patient compliance with antibiotic treatment for respiratory tract infections. J. Antimicrob. Chemother. (2002) 49:897-903.
   PubMed Web of Science ®Google Scholar